Navigation Links
Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56
Date:1/26/2011

on of long-term debt45,000-Income taxes payable28,82714,272Total Current Liabilities499,174402,744Long-term debt87,500-Deferred income taxes30,53198,945Other liabilities68,51662,251Total Liabilities685,721563,940Stockholders' Equity:Common stock774764Paid-in capital639,341587,995Retained earnings1,373,7051,305,451Accumulated other comprehensive income (loss)277(5,281)Treasury stock(734,276)(477,925)Total Stockholders' Equity1,279,8211,411,004Total Liabilities and Stockholders'  Equity$
,965,542$
,974,944COVANCE INC.CONSOLIDATED STATEMENTS OF CASH FLOWSFOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009(Dollars in thousands)Years Ended December 3120102009Cash flows from operating activities:  Net income$   68,254$ 175,882  Adjustments to reconcile net income to net cash provided byoperating activities:Depreciation and amortization103,02491,289Asset impairment charges119,229-Non-cash compensation expense associated with employee benefitand stock compensation plans32,28926,949Deferred income tax (benefit) provision(71,661)33,030Gain on sale of businesses-(9,681)Loss on disposal of property and equipment1,487998Equity investee earnings(807)(907)Changes in operating assets and liabilities, net of businessesacquired and sold:Accounts receivable23,959(54,937)Unbilled services6,55015,724Inventory(1,998)(12,720)Accounts payable(2,755)(5,163)Accrued liabilities20,097(8,072)Unearned revenue19,4114,174Income taxes payable14,797(1,176)Other assets and liabilities, net2,5473,699Net cash provided by operating activities334,423259,089Cash flows from investing activities:  Capital expenditures(126,278)(131,079)  Acquisition of businesses, net of cash acquired(20,994)(28,096)  Proceeds from sale of businesses-10,373  Other, net4729Net cash used in investing activities(147,225)(148,773)Cash flows from financing activities:  Net borrowings (repayments) under revolving credit facility35,000(50,000)  Borrowings under long-term debt100,00
'/>"/>
SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
2. Covance Receives Highest Level of Phase I Accreditation
3. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call
4. Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference
5. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
6. Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
7. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
8. Covance To Present At The 20th Annual Global Healthcare Services Conference
9. Covance To Present at the Deutsche Bank 35th Annual Health Care Conference
10. Covance to Present at Goldman Sachs 31st Annual Global Healthcare Conference
11. Covance to Present at William Blair & Companys 30th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
(Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon ... for the 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, ... to take participants from the basic training and fundamentals of nasal surgery through the ...
(Date:7/1/2015)... ... 01, 2015 , ... Did you know that infertility in men is more ... at Advanced Fertility Center of Texas (AFCT) would like to talk about some natural ... often considered to be a “woman’s issue,” male fertility factors can play a role ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Convoy of ... community celebration in the Twin Cities on Saturday, August 1, at Spring Lake Park ... community will provide more than $1 million worth of goods and services including free ...
(Date:7/1/2015)... ... July 01, 2015 , ... Scoliosis is a disorder in which the normally straight vertical ... affects 2 to 3 percent of the population, or an estimated 6 to 9 million ... children between the ages of 10 and 15. Most types of scoliosis are more common ...
(Date:7/1/2015)... ... July 01, 2015 , ... A Priority ... published a top ten list they hope will guide future mesothelioma research. Surviving ... read it now. , More than 450 mesothelioma patients, caregivers, and ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2
... your thoughts validated by others brings mental satisfaction, study finds ... with others often leads to a sense of satisfaction, and ... the "reward" area of the brain is activated when people ... and Denmark used functional MRI scans to monitor activity in ...
... caused mice to develop disease, study finds , THURSDAY, June ... have found a bacteria living in the gut may trigger ... The gut of all mammals is populated with thousands of ... developing a normal immune system. But some of these bacteria ...
... ... health and wellness. Learn how to improve the look and strength of your abdominal muscles ... information provided on this new Web site. , ... (PRWEB) June 17, 2010 -- A new Web site has been developed to help anyone ...
... ... (ENTA) is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will join ... ... , LLP (ENTA) is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who ...
... Compliance Advisory ... and the University of Virginia School of Medicine. , ... Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France ... sciences, openQ has formed a Compliance Advisory Board. Board members include experienced veterans from ...
... there are now new areas in which whole body magnetic ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... a review of possible uses, together with the limits of ... suitable for routine use in hospitals, as the procedure takes ...
Cached Medicine News:Health News:Shared Opinions Light Up Brain's 'Reward Center' 2Health News: Stomach Bacteria Might Trigger Rheumatoid Arthritis 2Health News: Stomach Bacteria Might Trigger Rheumatoid Arthritis 3Health News:New Web Site Provides Helpful Exercise and Nutrition Tips 2Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 2Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 3Health News:openQ Announces the Formation of a Compliance Advisory Board 2Health News:openQ Announces the Formation of a Compliance Advisory Board 3
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: